Mendrick D L, Rennke H G, Cotran R S, Springer T A, Abbas A K
Lab Invest. 1983 Jul;49(1):107-17.
To define the characteristics and target antigens (Ags) of nephrotoxic antibodies (Abs) and to analyze the factors that govern the evolution of Ab-mediated glomerular injury, we have prepared monoclonal Abs against rat glomerular Ags. BALB/c mice were immunized with Lewis rat cortex or glomeruli, and their spleens were removed and fused with hypoxanthine-aminopterin-thymidine supplement-sensitive myelomas. Hybrids were selected for production of Abs against Lewis rat kidney by indirect immunofluorescence. To date, more than 50 positive hybrids have been selected and their tissue reactivity defined by indirect immunofluorescence and immunoelectron microscopy. Of these, 14 are presented here in detail. One of these monoclonal Abs, K9/4, recognizes a unique Ag present exclusively on the cell surface of rat glomerular visceral epithelial cells. Four Abs (K12/2, K17/4, K12/5, and K12/8) recognize sites within the glomerular basement membrane; K12/2 and K17/4 also bind to vascular basement membranes of the rat, whereas K12/5 and K12/8 bind to glomerular basement membrane, tubular basement membranes, and vascular and epithelial basement membranes in all tissues of the rat. Two hybridomas (K6/1 and K6/3) recognize determinant(s) present on cell surfaces of endothelial and epithelial cells as well as within the glomerular basement membrane. All of these previously mentioned Abs are species restricted (i.e., they bind only to rat tissue) and, with the exception of K9/4, bind upon in vivo administration. Several others, however, recognize ubiquitous Ags that are present on intracellular structures in every species tested. The tissue distribution of these Ags suggests that they are present in contractile or cytoskeletal elements and, as expected from their intracellular location, monoclonal Abs directed against these components do not bind upon in vivo administration. Future studies will be directed at defining the antigenic composition of the glomerular capillary wall and the relevance of such Ags in immune-mediated glomerular injury.
为了明确肾毒性抗体(Abs)的特征和靶抗原(Ags),并分析影响抗体介导的肾小球损伤演变的因素,我们制备了针对大鼠肾小球抗原的单克隆抗体。用Lewis大鼠皮质或肾小球免疫BALB/c小鼠,然后取出它们的脾脏并与对次黄嘌呤 - 氨基蝶呤 - 胸腺嘧啶核苷补充剂敏感的骨髓瘤细胞进行融合。通过间接免疫荧光选择能够产生针对Lewis大鼠肾脏抗体的杂交瘤。到目前为止,已筛选出50多个阳性杂交瘤,并通过间接免疫荧光和免疫电子显微镜确定了它们的组织反应性。在此详细介绍其中14个。这些单克隆抗体中的一种,K9/4,识别一种仅存在于大鼠肾小球脏层上皮细胞表面的独特抗原。四种抗体(K12/2、K17/4、K12/5和K12/8)识别肾小球基底膜内的位点;K12/2和K17/4也与大鼠的血管基底膜结合,而K12/5和K12/8与大鼠所有组织中的肾小球基底膜、肾小管基底膜以及血管和上皮基底膜结合。两种杂交瘤(K6/1和K6/3)识别内皮细胞和上皮细胞表面以及肾小球基底膜内存在的决定簇。所有上述抗体均具有种属限制性(即它们仅与大鼠组织结合),并且除K9/4外,在体内给药后会结合。然而,其他几种抗体识别在每个测试物种的细胞内结构上都存在的普遍抗原。这些抗原的组织分布表明它们存在于收缩或细胞骨架成分中,并且正如从它们的细胞内位置所预期的那样,针对这些成分的单克隆抗体在体内给药后不会结合。未来的研究将致力于确定肾小球毛细血管壁的抗原组成以及这些抗原在免疫介导的肾小球损伤中的相关性。